Response to the letter to the Editor concerning our article "High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany"
Support Care Cancer. 2020 Jan;28(1):3-4.
doi: 10.1007/s00520-019-05126-z.
Epub 2019 Nov 8.